CTCBIO Inc Total Liabilities
CTCBIO Inc total liabilities. Based on the latest financial reports, CTCBIO Inc (060590) has total liabilities worth ₩77.43 Billion KRW (≈ $52.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CTCBIO Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of CTCBIO Inc (2011–2024)
Total liabilities of CTCBIO Inc from 2011 to 2024. This chart illustrates how CTCBIO Inc's total liabilities have evolved over time, based on quarterly financial data. Explore CTCBIO Inc (060590) investment intensity to see how much of total assets are deployed in long-term investments.
CTCBIO Inc Competitors by Total Liabilities
The table below lists competitors of CTCBIO Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Australian Unity Office Fund
AU:AOF
|
Australia | AU$815.00K |
|
Nice Information & Telecommunication Inc
KQ:036800
|
Korea | ₩822.77 Billion |
|
Better Life Group Co Ltd
TW:1805
|
Taiwan | NT$369.27 Million |
|
Gensource Potash Corporation
V:GSP
|
Canada | CA$14.73 Million |
|
Ctac N.V
AS:CTAC
|
Netherlands | €40.79 Million |
|
Kedawung Setia Industrial Tbk
JK:KDSI
|
Indonesia | Rp628.35 Billion |
|
Information and Communication Networks Public Company Limited
BK:ICN
|
Thailand | ฿1.23 Billion |
|
Hanil Forging Industrial Co. Ltd
KQ:024740
|
Korea | ₩154.56 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down CTCBIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 060590 current and non-current assets.
Liquidity & Leverage Metrics
CTCBIO Inc Total Liabilities Ratios Explained
CTCBIO Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CTCBIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CTCBIO Inc (2011–2024)
The table below shows the annual total liabilities of CTCBIO Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩84.07 Billion ≈ $56.97 Million |
-7.02% |
| 2023-12-31 | ₩90.42 Billion ≈ $61.27 Million |
-1.65% |
| 2022-12-31 | ₩91.94 Billion ≈ $62.30 Million |
+10.48% |
| 2021-12-31 | ₩83.21 Billion ≈ $56.39 Million |
-17.49% |
| 2020-12-31 | ₩100.86 Billion ≈ $68.35 Million |
-9.76% |
| 2019-12-31 | ₩111.76 Billion ≈ $75.74 Million |
+6.62% |
| 2018-12-31 | ₩104.82 Billion ≈ $71.03 Million |
-11.04% |
| 2017-12-31 | ₩117.82 Billion ≈ $79.84 Million |
+20.49% |
| 2016-12-31 | ₩97.78 Billion ≈ $66.26 Million |
+3.50% |
| 2015-12-31 | ₩94.47 Billion ≈ $64.02 Million |
+23.28% |
| 2014-12-31 | ₩76.63 Billion ≈ $51.93 Million |
+31.56% |
| 2013-12-31 | ₩58.25 Billion ≈ $39.47 Million |
-7.49% |
| 2012-12-31 | ₩62.96 Billion ≈ $42.67 Million |
+29.78% |
| 2011-12-31 | ₩48.52 Billion ≈ $32.88 Million |
-- |
About CTCBIO Inc
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergi… Read more